86 related articles for article (PubMed ID: 31870784)
1. Glucocorticoids uncover a critical role for ASH2L on BCL-X expression regulation in leukemia cells.
Rocha-Viegas L; Silbermins M; Ogara MF; Pellegrini JM; Nuñez SY; García VE; Vicent GP; Pecci A
Biochim Biophys Acta Gene Regul Mech; 2020 Jan; 1863(1):194475. PubMed ID: 31870784
[TBL] [Abstract][Full Text] [Related]
2. Low expression of ASH2L protein correlates with a favorable outcome in acute myeloid leukemia.
Butler JS; Qiu YH; Zhang N; Yoo SY; Coombes KR; Dent SY; Kornblau SM
Leuk Lymphoma; 2017 May; 58(5):1207-1218. PubMed ID: 28185526
[TBL] [Abstract][Full Text] [Related]
3. Activated glucocorticoid receptor interacts with the INHAT component Set/TAF-Ibeta and releases it from a glucocorticoid-responsive gene promoter, relieving repression: implications for the pathogenesis of glucocorticoid resistance in acute undifferentiated leukemia with Set-Can translocation.
Ichijo T; Chrousos GP; Kino T
Mol Cell Endocrinol; 2008 Feb; 283(1-2):19-31. PubMed ID: 18096310
[TBL] [Abstract][Full Text] [Related]
4. Staurosporine sensitizes T lymphoma cells to glucocorticoid-induced apoptosis: role of Nur77 and Bcl-2.
Kfir S; Sionov RV; Zafrir E; Zilberman Y; Yefenof E
Cell Cycle; 2007 Dec; 6(24):3086-96. PubMed ID: 18073527
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally activating Bcl-xL.
Gascoyne DM; Kypta RM; Vivanco Md
J Biol Chem; 2003 May; 278(20):18022-9. PubMed ID: 12637494
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid receptor alpha isoform-selective regulation of antiapoptotic genes in osteosarcoma cells: a new mechanism for glucocorticoid resistance.
Gross KL; Oakley RH; Scoltock AB; Jewell CM; Cidlowski JA
Mol Endocrinol; 2011 Jul; 25(7):1087-99. PubMed ID: 21527497
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoids repress bcl-X expression in lymphoid cells by recruiting STAT5B to the P4 promoter.
Rocha-Viegas L; Vicent GP; Barañao JL; Beato M; Pecci A
J Biol Chem; 2006 Nov; 281(45):33959-70. PubMed ID: 16959781
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal regulation of a glucocorticoid receptor-steroidogenic factor-1 transcription complex on the Dax-1 promoter by glucocorticoids and adrenocorticotropic hormone in the adrenal cortex.
Gummow BM; Scheys JO; Cancelli VR; Hammer GD
Mol Endocrinol; 2006 Nov; 20(11):2711-23. PubMed ID: 16857744
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential glucocorticoid receptor therapeutic targets in multiple myeloma.
Thomas AL; Coarfa C; Qian J; Wilkerson JJ; Rajapakshe K; Krett NL; Gunaratne PH; Rosen ST
Nucl Recept Signal; 2015; 13():e006. PubMed ID: 26715915
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis and modeling of glucocorticoid-controlled gene expression.
Chen DW; Lynch JT; Demonacos C; Krstic-Demonacos M; Schwartz JM
Pharmacogenomics; 2010 Nov; 11(11):1545-60. PubMed ID: 21121775
[TBL] [Abstract][Full Text] [Related]
11. ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription.
Zeng K; Wu Y; Wang C; Wang S; Sun H; Zou R; Sun G; Song H; Liu W; Sun N; Wei S; Liu W; Su Y; Zhou T; Zhang Y; Zhao Y
Cancer Sci; 2020 Jun; 111(6):2062-2077. PubMed ID: 32279431
[TBL] [Abstract][Full Text] [Related]
12. SKOV3 cells containing a truncated ARID1a protein have a restricted genome-wide response to glucocorticoids.
Stubbs FE; Birnie MT; Biddie SC; Lightman SL; Conway-Campbell BL
Mol Cell Endocrinol; 2018 Feb; 461():226-235. PubMed ID: 28942102
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Bcl-xL overcomes polyploidy resistance and leads to apoptotic cell death in acute myeloid leukemia cells.
Zhou W; Xu J; Gelston E; Wu X; Zou Z; Wang B; Zeng Y; Wang H; Liu A; Xu L; Liu Q
Oncotarget; 2015 Aug; 6(25):21557-71. PubMed ID: 26188358
[TBL] [Abstract][Full Text] [Related]
14. The transcription factor ETS1 promotes apoptosis resistance of senescent cholangiocytes by epigenetically up-regulating the apoptosis suppressor BCL2L1.
O'Hara SP; Splinter PL; Trussoni CE; Guicciardi ME; Splinter NP; Al Suraih MS; Nasser-Ghodsi N; Stollenwerk D; Gores GJ; LaRusso NF
J Biol Chem; 2019 Dec; 294(49):18698-18713. PubMed ID: 31659122
[TBL] [Abstract][Full Text] [Related]
15. Regulation of HOXA2 gene expression by the ATP-dependent chromatin remodeling enzyme CHD8.
Yates JA; Menon T; Thompson BA; Bochar DA
FEBS Lett; 2010 Feb; 584(4):689-93. PubMed ID: 20085832
[TBL] [Abstract][Full Text] [Related]
16. Agonist-activated glucocorticoid receptor inhibits binding of heat shock factor 1 to the heat shock protein 70 promoter in vivo.
Wadekar SA; Li D; Sánchez ER
Mol Endocrinol; 2004 Mar; 18(3):500-8. PubMed ID: 14673132
[TBL] [Abstract][Full Text] [Related]
17. Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.
Martens C; Bilodeau S; Maira M; Gauthier Y; Drouin J
Mol Endocrinol; 2005 Apr; 19(4):885-97. PubMed ID: 15591535
[TBL] [Abstract][Full Text] [Related]
18. SPG6 supports development of acute myeloid leukemia by regulating BMPR2-Smad-Bcl-2/Bcl-xl signaling.
Chen J; Li C; Zhan R; Yin Y
Biochem Biophys Res Commun; 2018 Jun; 501(1):220-225. PubMed ID: 29715457
[TBL] [Abstract][Full Text] [Related]
19. Dysfunctional glucocorticoid receptor with a single point mutation ablates the CCAAT/enhancer binding protein-dependent growth suppression response in a steroid-resistant rat hepatoma cell variant.
Ramos RA; Meilandt WJ; Wang EC; Firestone GL
FASEB J; 1999 Jan; 13(1):169-80. PubMed ID: 9872941
[TBL] [Abstract][Full Text] [Related]
20. Suppression of granulocyte-macrophage colony-stimulating factor expression by glucocorticoids involves inhibition of enhancer function by the glucocorticoid receptor binding to composite NF-AT/activator protein-1 elements.
Smith PJ; Cousins DJ; Jee YK; Staynov DZ; Lee TH; Lavender P
J Immunol; 2001 Sep; 167(5):2502-10. PubMed ID: 11509589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
